Eleanor G Pope

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Recombinant Human

Transcription Factor

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Meijie Tian, Jun S Wei, Adam Tai-Chi Cheuk, David Milewski, Zhongmei Zhang, Yong Yean Kim, Hsien-Chao Chou, Can Liu, Sherif Badr, Eleanor G Pope, Abdelrahman Rahmy, Jerry T Wu, Michael C Kelly, Xinyu Wen, Javed Khan
CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma. Nature communications 15 (1) (2024)
Meijie Tian, Jun S Wei, Adam Tai-Chi Cheuk, David Milewski, Zhongmei Zhang, Yong Yean Kim, Hsien-Chao Chou, Can Liu, Sherif Badr, Eleanor G Pope, Abdelrahman Rahmy, Jerry T Wu, Michael C Kelly, Xinyu Wen, Javed Khan
CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma. Nature communications 15 (1) (2024)
Meijie Tian, Jun S Wei, Adam Tai-Chi Cheuk, David Milewski, Zhongmei Zhang, Yong Yean Kim, Hsien-Chao Chou, Can Liu, Sherif Badr, Eleanor G Pope, Abdelrahman Rahmy, Jerry T Wu, Michael C Kelly, Xinyu Wen, Javed Khan
CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma. Nature communications 15 (1) (2024)
Meijie Tian, Jun S Wei, Adam Tai-Chi Cheuk, David Milewski, Zhongmei Zhang, Yong Yean Kim, Hsien-Chao Chou, Can Liu, Sherif Badr, Eleanor G Pope, Abdelrahman Rahmy, Jerry T Wu, Michael C Kelly, Xinyu Wen, Javed Khan
CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma. Nature communications 15 (1) (2024)